HLA-Cw*04 and hepatitis C virus persistence

被引:148
作者
Thio, CL
Gao, XJ
Goedert, JJ
Vlahov, D
Nelson, KE
Hilgartner, MW
O'Brien, SJ
Karacki, P
Astemborski, J
Carrington, M
Thomas, DL
机构
[1] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA
[3] NCI, Lab Genom Divers, Frederick, MD 21701 USA
[4] NCI, Div Canc Epidemiol & Genet, Viral Epidemiol Branch, Rockville, MD USA
[5] Cornell Med Ctr, New York Presbyterian Hosp, Dept Pediat, New York, NY USA
[6] New York Acad Med, New York, NY USA
关键词
D O I
10.1128/JVI.76.10.4792-4797.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In studies of acute hepatitis C virus (HCV) infection, the early host immune response is one of the determinants of viral persistence. The class I human leukocyte antigens (HLA), which present foreign antigen to cytolytic T cells, are integral components of this response. We hypothesized that the highly polymorphic HLA genes affect the outcome of an HCV infection. To test this hypothesis, we molecularly typed 231 persons with well-documented clearance of an HCV infection and 444 matched persistently infected persons. HLA-A*1101 (odds ratio [OR], 0.49; 95% confidence interval [95% CI], 0.27 to 0.89), HLA-B*57 (OR, 0.62; 95% Cl, 0.39 to 1.00), and HLA-Cw*0102 (OR, 0.43; 95% CI, 0.21 to 0.89) were associated with viral clearance, whereas HLA-A*2301 (OF, 1.78; 95% CI, 1.01 to 3.11) and HLA-Cw*04 (OR, 1.78; 95% CI, 1.21 to 2.59) were associated with viral persistence. HLA-Cw*04 is in strong linkage disequilibrium with HLA-B*53 and HLA-B*35, but only HLA-B*53 (OR, 1.70, 95% CI, 0.95 to 3.06) and the Cw*04-B*53 haplotype (OR, 1.76; 95% CI, 0.94 to 3.26) were weakly associated with viral persistence. HLA-B*53 has similar, but not necessarily identical, binding specificity to some HLA-B*35 subtypes (B*35-Px group). The association with the B*35-Px group was less strong than with HLA-B*53 alone. The association of HLA-Cw*04 with HCV persistence was codominant (two copies of the gene were more strongly associated with persistence than one copy). However, HLA*04 was not associated with HCV RNA levels among the persistently infected individuals. Since Cw*04 is a ligand for the killer immunoglobulin-like receptors on natural killer cells, these cells may be involved in recovery from HCV infection. Further investigation is needed to understand the relationship between class I alleles and HCV clearance.
引用
收藏
页码:4792 / 4797
页数:6
相关论文
共 28 条
[1]  
[Anonymous], 1997, HEPATOLOGY, V26, pS2
[2]   OVERLAP IN THE REPERTOIRES OF PEPTIDES BOUND IN-VIVO BY A GROUP OF RELATED CLASS-I HLA-B ALLOTYPES [J].
BARBER, LD ;
GILLECECASTRO, B ;
PERCIVAL, L ;
LI, XB ;
CLAYBERGER, C ;
PARHAM, P .
CURRENT BIOLOGY, 1995, 5 (02) :179-190
[3]   Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin [J].
Barrett, S ;
Ryan, E ;
Crowe, J .
JOURNAL OF HEPATOLOGY, 1999, 30 (06) :979-983
[4]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[5]   The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells [J].
Cohen, GB ;
Gandhi, RT ;
Davis, DM ;
Mandelboim, O ;
Chen, BK ;
Strominger, JL ;
Baltimore, D .
IMMUNITY, 1999, 10 (06) :661-671
[6]   Analysis of a successful immune response against hepatitis C virus [J].
Cooper, S ;
Erickson, AL ;
Adams, EJ ;
Kansopon, J ;
Weiner, AJ ;
Chien, DY ;
Houghton, M ;
Parham, P ;
Walker, CM .
IMMUNITY, 1999, 10 (04) :439-449
[7]   Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection [J].
Corado, J ;
Toro, F ;
Rivera, H ;
Bianco, NE ;
Deibis, L ;
DeSanctis, JB .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (03) :451-457
[8]   HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women [J].
Costello, C ;
Tang, JM ;
Rivers, C ;
Karita, E ;
Meizen-Derr, J ;
Allen, S ;
Kaslow, RA .
AIDS, 1999, 13 (14) :1990-1991
[9]   Innate and adaptive lymphoid cells in the human liver [J].
Doherty, DG ;
O'Farrelly, C .
IMMUNOLOGICAL REVIEWS, 2000, 174 :5-20
[10]   A PROSPECTIVE-STUDY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INFECTION AND THE DEVELOPMENT OF AIDS IN SUBJECTS WITH HEMOPHILIA [J].
GOEDERT, JJ ;
KESSLER, CM ;
ALEDORT, LM ;
BIGGAR, RJ ;
ANDES, WA ;
WHITE, GC ;
DRUMMOND, JE ;
VAIDYA, K ;
MANN, DL ;
EYSTER, ME ;
RAGNI, MV ;
LEDERMAN, MM ;
COHEN, AR ;
BRAY, GL ;
ROSENBERG, PS ;
FRIEDMAN, RM ;
HILGARTNER, MW ;
BLATTNER, WA ;
KRONER, B ;
GAIL, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) :1141-1148